100 related articles for article (PubMed ID: 24466048)
1. The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surface.
Gorrasi A; Li Santi A; Amodio G; Alfano D; Remondelli P; Montuori N; Ragno P
PLoS One; 2014; 9(1):e86352. PubMed ID: 24466048
[TBL] [Abstract][Full Text] [Related]
2. A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.
Hillig T; Engelholm LH; Ingvarsen S; Madsen DH; Gårdsvoll H; Larsen JK; Ploug M; Danø K; Kjøller L; Behrendt N
J Biol Chem; 2008 May; 283(22):15217-23. PubMed ID: 18362146
[TBL] [Abstract][Full Text] [Related]
3. Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.
Nalla AK; Asuthkar S; Bhoopathi P; Gujrati M; Dinh DH; Rao JS
PLoS One; 2010 Sep; 5(9):e13006. PubMed ID: 20886051
[TBL] [Abstract][Full Text] [Related]
4. VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.
Alexander RA; Prager GW; Mihaly-Bison J; Uhrin P; Sunzenauer S; Binder BR; Schütz GJ; Freissmuth M; Breuss JM
Cardiovasc Res; 2012 Apr; 94(1):125-35. PubMed ID: 22287577
[TBL] [Abstract][Full Text] [Related]
5. Role of Formyl Peptide Receptors and β-Arrestin-1 in suPAR Signal Transduction in Mouse Podocytes: Interactions with αVβ3-Integrin.
Kim EY; Dryer SE
Cells; 2024 Jan; 13(2):. PubMed ID: 38247863
[TBL] [Abstract][Full Text] [Related]
6. FPR1: A critical gatekeeper of the heart and brain.
Zhangsun Z; Dong Y; Tang J; Jin Z; Lei W; Wang C; Cheng Y; Wang B; Yang Y; Zhao H
Pharmacol Res; 2024 Apr; 202():107125. PubMed ID: 38438091
[TBL] [Abstract][Full Text] [Related]
7. Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1.
Bednar F; Song C; Bardi G; Cornwell W; Rogers TJ
J Immunol; 2014 Jun; 192(11):5305-13. PubMed ID: 24778447
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formation.
Gao JL; Weaver JD; Tuo J; Wang LQ; Siwicki M; Despres D; Lizak M; Schneider EH; Kovacs W; Maminishkis A; Chen K; Yoshimura T; Ming Wang J; Chao Chan C; Murphy PM
FASEB J; 2021 Feb; 35(2):e21315. PubMed ID: 33538366
[TBL] [Abstract][Full Text] [Related]
9. Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models.
Francavilla F; Sarcina F; Schepetkin IA; Kirpotina LN; Contino M; Schirizzi A; De Leonardis G; Khlebnikov AI; D'Alessandro R; Quinn MT; Lacivita E; Leopoldo M
Eur J Med Chem; 2023 Dec; 261():115854. PubMed ID: 37839346
[TBL] [Abstract][Full Text] [Related]
10. Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.
Mythreye K; Blobe GC
Cell Signal; 2009 Nov; 21(11):1548-58. PubMed ID: 19427900
[TBL] [Abstract][Full Text] [Related]
11. FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and is able to promote the migration and phagocytosis of macrophages.
Wang W; Li T; Wang X; Yuan W; Cheng Y; Zhang H; Xu E; Zhang Y; Shi S; Ma D; Han W
Cell Mol Immunol; 2015 Sep; 12(5):615-24. PubMed ID: 25109685
[TBL] [Abstract][Full Text] [Related]
12. Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.
Bifulco K; Votta G; Ingangi V; Di Carluccio G; Rea D; Losito S; Montuori N; Ragno P; Stoppelli MP; Arra C; Carriero MV
Oncotarget; 2014 Jun; 5(12):4154-69. PubMed ID: 24980826
[TBL] [Abstract][Full Text] [Related]
13. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts.
Grove LM; Southern BD; Jin TH; White KE; Paruchuri S; Harel E; Wei Y; Rahaman SO; Gladson CL; Ding Q; Craik CS; Chapman HA; Olman MA
J Biol Chem; 2014 May; 289(18):12791-804. PubMed ID: 24644284
[TBL] [Abstract][Full Text] [Related]
15. Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity.
Portelli MA; Bhaker S; Pang V; Bates DO; Johnson SR; Mazar AP; Shaw D; Brightling C; Sayers I
Clin Transl Allergy; 2023 Oct; 13(10):e12293. PubMed ID: 37876037
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.
Alfano D; Franco P; Stoppelli MP
Front Cell Dev Biol; 2022; 10():818616. PubMed ID: 35493073
[TBL] [Abstract][Full Text] [Related]
17. Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells.
Alfieri M; Li Santi A; Meo L; Giudice V; Selleri C; Ragno P
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454884
[TBL] [Abstract][Full Text] [Related]
18. The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.
Li Santi A; Napolitano F; Montuori N; Ragno P
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923400
[TBL] [Abstract][Full Text] [Related]
19. TLR4 Response to LPS Is Reinforced by Urokinase Receptor.
Kiyan Y; Tkachuk S; Rong S; Gorrasi A; Ragno P; Dumler I; Haller H; Shushakova N
Front Immunol; 2020; 11():573550. PubMed ID: 33362762
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
